+48.2%
GSK vs SHAK
-22.8%
+71.0%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | SHAK | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +3.2% | -3.1% | -0.1% |
| 7D | -3.5% | -8.3% | +4.8% | -3.1% |
| 30D | -3.4% | -12.6% | +9.2% | -2.9% |
| 3M | -8.1% | +9.1% | -17.2% | -8.6% |
| 6M | -11.1% | -31.2% | +20.1% | -10.1% |
| YTD | +0.7% | -21.6% | +22.3% | +1.3% |
| 1Y | +20.1% | -38.8% | +58.9% | +22.0% |
| 3Y | +46.1% | +0.6% | +45.5% | +43.8% |
| All | +48.2% | -22.8% | +71.0% | +43.2% |
Cumulative growth
Daily Returns
Daily percentage return beside SHAK.
Daily Out/Under-Performance
Portfolio return minus SHAK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SHAK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded SHAK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling